Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Rune Nielsen, Hannu Kankaanranta, Leif Bjermer, Peter Lange, Sofie Arnetorp, Morten Hedegaard, Anna Stenling, Nicole Mittmann

7 Citationer (Scopus)

Abstrakt

Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).
OriginalsprogEngelsk
TidsskriftRespiratory medicine
Vol/bind107
Udgave nummer11
Sider (fra-til)1709-21
Antal sider13
ISSN0954-6111
DOI
StatusUdgivet - nov. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries'. Sammen danner de et unikt fingeraftryk.

Citationsformater